• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Bain Capital buys Italmatch in SBO

  • Alessia Argentieri
  • Alessia Argentieri
  • 28 June 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Bain Capital Private Equity has acquired Italmatch Chemicals, an Italian speciality chemicals company, from Ardian.

According to press reports, the deal was valued at around €700m.

Unquote reported in March that Ardian was planning to sell Italmatch and was holding talks with international private equity funds.

Italmatch Chemicals

  • DEAL:

    SBO

  • LOCATION:

    Genoa

  • SECTOR:

    Speciality chemicals

  • FOUNDED:

    1997

  • TURNOVER:

    €400m

  • STAFF:

    780

  • VENDOR:

    Ardian

The SBO ends a four-year holding period for Ardian, which acquired Italmatch from Mandarin Capital Partners and the Malacalza family in a deal that valued the company at around €220m, according to press reports. Ardian bought a 67.7% stake from Mandarin and a minority holding from the Malacalza family, reaching a total ownership of 88%, while the company's management retained a 12% stake.

Ardian deployed capital from its  AXA LBO fund V, closed on €2.41bn in October 2013, shortly after the GP finalised its spinout from parent company Axa.  The stake owned by Ardian was subsequently reduced to 81% in 2016 following a build-up transaction, Unquote understands.

Under Ardian's ownership, Italmatch doubled its sales and grew both organically and through acquisitions, with nine add-ons completed worldwide.

Bain Capital is currently investing its fourth Europe-focused fund, Bain Capital Europe IV, which held a final close in 2014 on €3.5bn. The vehicle is now around 70% deployed and the firm is raising a new pan-European fund with a €4.5bn target, which is expected to hold a final close by the end of the year.

Previous funding
Investindustral backed Italmatch in 1997 alongside Iniziativa Piemonte. It exited the investment in 2000, when it sold its stake to Argos Soditic and Iniziativa Piemonte. Subsequently, Investindustrial reacquired a 90% holding in the business in 2004 from Argos and Iniziativa Piemonte, while the company's management team retained the remaining 10% stake.

Mandarin and the Malacalza family bought a 90% stake in Italmatch from Investindustrial in 2010, by acquiring 70% and 20% of the business respectively, in a deal that valued the company at around €100m. The remaining 10% was retained by Italmatch's management team. Ardian then acquired the business in 2014.

Company
Established in 1997 and headquartered in Genoa, Italmatch is a manufacturer of speciality chemical additives, operating across four key business units: water and oil treatment; lubricants; flame retardants and plastic additives; and performance products and personal care.

Italmatch has 17 manufacturing sites, with seven located in Europe, five in North America and five in Asia Pacific. The company employs 780 staff across Europe, the US and Asia, and generated revenues of approximately €400m in 2017.

People
Ardian – Yann Chareton (managing director Italy).
Bain Capital Private Equity – Ivano Sessa (managing director).
Italmatch – Sergio Iorio (CEO).

Advisers
Company
– Studio Nunziante Magrone (legal); Studio Legale Tributario STLex (tax).
Vendor – Goldman Sachs (M&A); BNP Paribas (M&A); Fineurop Soditic (M&A); Giovannelli e Associati (legal); Gitti and Partners (tax); Advancy (commercial due diligence).
Acquirer – Rothschild (M&A); Lincoln International (M&A); Latham & Watkins (legal); Pirola Pennuto Zei & Associati (tax); PwC (tax).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Southern Europe
  • Industrials
  • Ardian (formerly Axa PE)
  • Bain Capital Europe
  • Italy
  • Secondary buyout
  • Goldman Sachs
  • Latham & Watkins
  • Rothschild
  • Lincoln International

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013